Skip to main content
Fig. 1 | Biomarker Research

Fig. 1

From: Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Fig. 1

An overview of predictive biomarkers for immune checkpoint inhibitors efficacy. Key elements in predictive biomarker development for the efficacy of immune checkpoint inhibitors therapy are briefly described in the figure, including tumor cells-related biomarkers, tumor immune microenvironment phenotype biomarkers, circulating factors, host-related factors, and immune-related adverse events

Back to article page